์•ˆ๋…•ํ•˜์„ธ์š”. 

์˜๋ฃŒ๊ฒฝ์˜ ๋‰ด์Šค๋ ˆํ„ฐ์ž…๋‹ˆ๋‹ค.๐Ÿฃ


์กฐ๊ธˆ์”ฉ ๊ฐ€์„์˜ ๊ธฐ์šด์ด ์ง™์–ด์ง€๋Š” 9์›”์ž…๋‹ˆ๋‹ค.


์ผ๊ต์ฐจ์— ๊ฑด๊ฐ• ์œ ์˜ํ•˜์‹œ๊ณ , ๊ธฐ๋ถ„ ์ข‹์€ ํ•œ ์ฃผ ๋ณด๋‚ด์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.


๋ฆฌ๋ทฐํ•œ ๋…ผ๋ฌธ์€ ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค.


  • Wei Fu, Yuting Qian, Seyed M. Karimi, Hamid Zarei, Xi Chen. (2026). Risk Adjustment for Alzheimer Disease and Related Dementias in Medicare Advantage and Health Care Experiences. JAMA Network Open.

  • Zehui Zhou, Jason D. Buxbaum, Andrew M. Ryan. (2026). Mandatory Value-Based Payment Programs and Hospital Administrative Costs. JAMA Health Forum.

๐Ÿ“‘ ์ €์ž‘๊ถŒ ์•ˆ๋‚ด

  • ์˜คํ”ˆ ์•ก์„ธ์Šค(CC BY ๋“ฑ) ๋˜๋Š” ๋ฒˆ์—ญยท์š”์•ฝ์ด ํ—ˆ์šฉ๋œ ๋…ผ๋ฌธ๋งŒ ๋‰ด์Šค๋ ˆํ„ฐ์— ๋ฆฌ๋ทฐ๋กœ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

  • ์ œํ•œ๋œ ๋…ผ๋ฌธ์€ ์›๋ฌธ ๋งํฌ์™€ ๊ฐ„๋‹จํ•œ ์ฝ”๋ฉ˜ํŠธ๋งŒ ์ œ๊ณตํ•˜๋ฉฐ, ์—ฐ๊ตฌ์‹ค ๊ตฌ์„ฑ์›๋“ค์€ ๋‚ด๋ถ€ ์•„์นด์ด๋ธŒ๋ฅผ ์ฐธ๊ณ ํ•ด์ฃผ์„ธ์š”๐Ÿฅฐ

Risk Adjustment for Alzheimer Disease and Related Dementias
in Medicare Advantage and Health Care Experiences

์ €์ž: WeiFu, YutingQian, SeyedM.Karimi, HamidZarei, XiChen

์ €๋„/IF/์—ฐ๋„: JAMA Network Open/ IF 11.7 / 2026

Copyright: CC-BY-4.0 (๋ณต์‚ฌ ๋ฐ ๋ฐฐํฌ, ์ƒ์—…์  ์‚ฌ์šฉ, 2์ฐจ ์ €์ž‘๋ฌผ ์ œ์ž‘ ๊ฐ€๋Šฅ)

DOI: 10.1001/jamanetworkopen.2026.1796

๐Ÿ”Ž ์—ฐ๊ตฌ ๋ฐฐ๊ฒฝ
  • (ADRD ์œ„ํ—˜์กฐ์ • ์žฌ๋„์ž…) Medicare Advantage(MA)๋Š” ๊ฐ€์ž…์ž์˜ ๊ฑด๊ฐ•์œ„ํ—˜์— ๋”ฐ๋ผ ๋ณดํ—˜์‚ฌ ์ง€๊ธ‰์•ก์„ ์กฐ์ •ํ•˜๋Š” ์ธ๋‘์ œ ๋ฐฉ์‹์ด๋ฉฐ, ADRD๋Š” 2014๋…„๋ถ€ํ„ฐ ์œ„ํ—˜์กฐ์ • ๋ชจํ˜•์—์„œ ์ œ์™ธ๋˜์—ˆ๋‹ค๊ฐ€ 2020๋…„ ๋‹ค์‹œ HCC์— ํฌํ•จ๋จ.

  • (์ •์ฑ…์  ๋ฌธ์ œ) ADRD์™€ ๊ฐ™์€ ๊ณ ๋น„์šฉ ์งˆํ™˜์ด ์ถฉ๋ถ„ํžˆ ๋ฐ˜์˜๋˜์ง€ ์•Š์œผ๋ฉด ๋ณดํ—˜์‚ฌ๊ฐ€ ํ•ด๋‹น ํ™˜์ž์˜ ์˜๋ฃŒ์„œ๋น„์Šค์— ํˆฌ์žํ•  ๊ฒฝ์ œ์  ์œ ์ธ์ด ๋‚ฎ์•„์งˆ ์ˆ˜ ์žˆ์Œ.

  • (์—ฐ๊ตฌ ๋ชฉ์ ) 2020๋…„ ADRD ์œ„ํ—˜์กฐ์ • ์žฌ๋„์ž… ์ดํ›„, MA ๊ฐ€์ž… ADRD ํ™˜์ž์˜ ์˜๋ฃŒ ์ ‘๊ทผ์„ฑ, ์˜๋ฃŒ๋น„ ๋ถ€๋‹ด, ์ „๋ฌธ์˜ ์ ‘๊ทผ ๋ฐ ์˜๋ฃŒ์˜ ์งˆ ๋งŒ์กฑ๋„๊ฐ€ ๋ณ€ํ™”ํ–ˆ๋Š”์ง€ ํ‰๊ฐ€ํ•จ.


๐Ÿงช ์—ฐ๊ตฌ๋ฐฉ๋ฒ•

  • (์—ฐ๊ตฌ์„ค๊ณ„) 2015โ€“2022๋…„ Medicare Current Beneficiary Survey(MCBS)๋ฅผ ์ด์šฉํ•œ ๋ฐ˜๋ณต ํšก๋‹จ๋ฉด ์—ฐ๊ตฌ๋กœ, MA ๊ฐ€์ž…์ž 5,353๊ฑด์„ ๋ถ„์„ํ•จ.

  • (๋น„๊ต์ง‘๋‹จ) ADRD ํ™˜์ž 1,629๊ฑด์„ treatment group์œผ๋กœ, ADRD๋Š” ์—†์ง€๋งŒ ๋‡Œ์กธ์ค‘ยท๋งˆ๋น„ยทํŒŒํ‚จ์Šจ๋ณ‘์„ ๊ฐ€์ง„ ํ™˜์ž 3,724๊ฑด์„ control group์œผ๋กœ ์„ค์ •ํ•จ.

  • (๋ถ„์„๋ฐฉ๋ฒ•) 2020๋…„ ์ •์ฑ… ์ „ํ›„ ๋‘ ์ง‘๋‹จ์˜ ๋ณ€ํ™” ์ฐจ์ด๋ฅผ Difference-in-Differences(DID)๋กœ ๋ถ„์„ํ•˜๊ณ , event study์™€ placebo test ๋“ฑ์„ ํ†ตํ•ด ๊ฒฐ๊ณผ์˜ ๊ฐ•๊ฑด์„ฑ์„ ํ™•์ธํ•จ.


๐Ÿ“Š ์ฃผ์š” ๊ฒฐ๊ณผ

  • (์˜๋ฃŒ ์ ‘๊ทผ์„ฑ ๊ฐœ์„ ) ADRD ์œ„ํ—˜์กฐ์ • ์žฌ๋„์ž… ์ดํ›„ ํ•„์š”ํ•œ ์˜๋ฃŒ์„œ๋น„์Šค ์ด์šฉ์— ์–ด๋ ค์›€์„ ๊ฒฝํ—˜ํ•  ํ™•๋ฅ ์ด ๋น„๊ต๊ตฐ ๋Œ€๋น„ 6.6%p ๊ฐ์†Œํ•จ(P=.005).

  • (์˜๋ฃŒ๋น„ ๋ถ€๋‹ด ๊ฐ์†Œ) ์˜๋ฃŒ๋น„ ๋ถ€๋‹ด์„ ๊ฒฝํ—˜ํ•  ํ™•๋ฅ ๋„ ๋น„๊ต๊ตฐ ๋Œ€๋น„ 9.2%p ๊ฐ์†Œํ•จ(P=.009).

  • (์˜๋ฃŒ์˜ ์งˆ ๋ณ€ํ™”๋Š” ์ œํ•œ์ ) ์ „๋ฌธ์˜ ์ ‘๊ทผ ๋งŒ์กฑ๋„์™€ ์ „๋ฐ˜์ ์ธ ์˜๋ฃŒ์˜ ์งˆ ๋งŒ์กฑ๋„์—์„œ๋Š” ํ†ต๊ณ„์ ์œผ๋กœ ์œ ์˜ํ•œ ๋ณ€ํ™”๊ฐ€ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์Œ.


โœ… ์‹œ์‚ฌ์ 

  • (์œ„ํ—˜์กฐ์ •์˜ ์ค‘์š”์„ฑ) ๊ณ ์œ„ํ—˜ยท๊ณ ๋น„์šฉ ํ™˜์ž์˜ ํŠน์„ฑ์„ ์ง€๊ธ‰์•ก์— ์ ์ ˆํžˆ ๋ฐ˜์˜ํ•˜๋Š” ๊ฒƒ์€ ๋ณดํ—˜์‚ฌ๊ฐ€ ํ•ด๋‹น ํ™˜์ž๋ฅผ ํšŒํ”ผํ•˜๊ฑฐ๋‚˜ ์„œ๋น„์Šค๋ฅผ ์ œํ•œํ•  ์œ ์ธ์„ ์ค„์ด๋Š” ๋ฐ ์ค‘์š”ํ•จ.

  • (์ง€๊ธ‰์ œ๋„์™€ ํ™˜์ž๊ฒฝํ—˜์˜ ์—ฐ๊ฒฐ) ๋ณดํ—˜์‚ฌ์— ๋Œ€ํ•œ ๋ณด์ƒ์ฒด๊ณ„ ๋ณ€ํ™”๋งŒ์œผ๋กœ๋„ ํ™˜์ž๊ฐ€ ๊ฒฝํ—˜ํ•˜๋Š” ์˜๋ฃŒ ์ ‘๊ทผ์„ฑ๊ณผ ๊ฒฝ์ œ์  ๋ถ€๋‹ด์ด ๊ฐœ์„ ๋  ๊ฐ€๋Šฅ์„ฑ์„ ๋ณด์—ฌ์คŒ.

  • (์ถ”๊ฐ€ ์ •์ฑ… ํ•„์š”) ์œ„ํ—˜์กฐ์ •๋งŒ์œผ๋กœ ์ „๋ฌธ์˜ ์ ‘๊ทผ์ด๋‚˜ ์˜๋ฃŒ์˜ ์งˆ๊นŒ์ง€ ๊ฐœ์„ ๋˜์ง€๋Š” ์•Š์•„, ์ง„๋ฃŒ ๋„คํŠธ์›Œํฌ ํ™•๋Œ€๋‚˜ care coordination ๋“ฑ ์ถ”๊ฐ€์ ์ธ ์ •์ฑ…์ด ํ•„์š”ํ•จ.



๐Ÿ’ฌ ๋žฉ ์ฝ”๋ฉ˜ํŠธ
  • (ํšจ๊ณผ์˜ ํฌ๊ธฐ ํ•ด์„ ํ•œ๊ณ„) ADRD๊ฐ€ ์œ„ํ—˜์กฐ์ •์— ํฌํ•จ๋˜๋ฉด์„œ ๋ณดํ—˜์‚ฌ ์ง€๊ธ‰์•ก์ด ์–ผ๋งˆ๋‚˜ ์ฆ๊ฐ€ํ–ˆ๋Š”์ง€๋Š” ๋…ผ๋ฌธ์—์„œ ๊ตฌ์ฒด์ ์œผ๋กœ ์ œ์‹œํ•˜์ง€ ์•Š์•„, ์ถ”๊ฐ€ ๋ณด์ƒ ๊ทœ๋ชจ์™€ ํ™˜์ž๊ฒฝํ—˜ ๊ฐœ์„  ์ •๋„๋ฅผ ์ง์ ‘ ์—ฐ๊ฒฐํ•˜๊ธฐ ์–ด๋ ค์›€.

  • (๋ฐ˜๋ณต ํšก๋‹จ๋ฉด DID์˜ ํ•œ๊ณ„) ๋™์ผํ•œ ํ™˜์ž๋ฅผ ์ •์ฑ… ์ „ํ›„๋กœ ์ถ”์ ํ•œ ๊ฒƒ์ด ์•„๋‹ˆ๋ผ ์„œ๋กœ ๋‹ค๋ฅธ ํ‘œ๋ณธ์„ ๋น„๊ตํ•œ ์—ฐ๊ตฌ์ด๋ฏ€๋กœ, 2020๋…„ ์ดํ›„ MA์— ๊ฐ€์ž…ํ•˜๊ฑฐ๋‚˜ ADRD๋กœ ์ง„๋‹จ๋œ ํ™˜์ž์˜ ๊ตฌ์„ฑ ๋ณ€ํ™”๊ฐ€ ๊ฒฐ๊ณผ์— ์˜ํ–ฅ์„ ๋ฏธ์ณค์„ ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ์Œ.

  • (๊ฐ๊ด€์  ๊ฒฐ๊ณผ ํ™•์ธ ๋ถˆ๊ฐ€) ADRD ์ง„๋‹จ๊ณผ ํ™˜์ž๊ฒฝํ—˜์ด ์ฃผ๋กœ ์„ค๋ฌธ์— ๊ธฐ๋ฐ˜ํ•˜๋ฉฐ ์ฒญ๊ตฌ์ž๋ฃŒ์™€ ์—ฐ๊ณ„๋˜์ง€ ์•Š์•„, ์‹ค์ œ ์˜๋ฃŒ์ด์šฉ๋Ÿ‰ยท๋ณธ์ธ๋ถ€๋‹ด๊ธˆยท์ž„์ƒ ๊ฒฐ๊ณผ๊ฐ€ ๊ฐœ์„ ๋˜์—ˆ๋Š”์ง€๋Š” ํ™•์ธํ•  ์ˆ˜ ์—†์Œ.

  • (์ž‘๋™๊ธฐ์ „์˜ ๋ถˆ๋ช…ํ™•์„ฑ) ์œ„ํ—˜์กฐ์ • ๊ฐœํŽธ์ด ์–ด๋–ค ๋ณดํ—˜์‚ฌ ํ–‰๋™ ๋ณ€ํ™”๋ฅผ ๊ฑฐ์ณ ์˜๋ฃŒ ์ ‘๊ทผ์„ฑ๊ณผ ์˜๋ฃŒ๋น„ ๋ถ€๋‹ด ๊ฐœ์„ ์œผ๋กœ ์ด์–ด์กŒ๋Š”์ง€๋ฅผ ์ง์ ‘ ๋ถ„์„ํ•˜์ง€ ์•Š์•˜๋‹ค๋Š” ์ ์€ ์•„์‰ฌ์›€.


Mandatory Value- Based Payment Programs and Hospital Administrative Costs

์ €์ž: ZehuiZhou, JasonD.Buxbaum, AndrewM.Ryan

์ €๋„/IF/์—ฐ๋„: JAMA Health Forum / IF 12.5 / 2026

Copyright: CC-BY-NC-ND (๋ณต์‚ฌยท๋ฐฐํฌยท2์ฐจ ์ €์ž‘๋ฌผ ์ œ์ž‘ ๋ถˆ๊ฐ€)

DOI: 10.1001/jamahealthforum.2026.2503

๐Ÿ’ฌ ๋žฉ ์ฝ”๋ฉ˜ํŠธ
  • (Synthetic DID์˜ ํ•„์š”์„ฑ) ์ €์ž๋“ค์€ treatment ๋ณ‘์›๊ณผ ๋น„๊ต๋ณ‘์› ๊ฐ„ ํŠน์„ฑ ๋ฐ ์‚ฌ์ „ ์ถ”์„ธ์˜ ์ฐจ์ด๋ฅผ ๋ณด์™„ํ•˜๊ธฐ ์œ„ํ•ด Synthetic DID๋ฅผ ์‚ฌ์šฉํ–ˆ์ง€๋งŒ, ์ผ๋ฐ˜ DID๋กœ ๋ถ„์„ํ–ˆ์„ ๋•Œ ํ‰ํ–‰์ถ”์„ธ ๊ฐ€์ •์ด ์–ด๋А ์ •๋„ ๋ฌธ์ œ๊ฐ€ ๋˜๋Š”์ง€ ๋˜๋Š” ๋‘ ๋ฐฉ๋ฒ•์˜ ๊ฒฐ๊ณผ๊ฐ€ ์–ผ๋งˆ๋‚˜ ๋‹ค๋ฅธ์ง€ ์ œ์‹œํ•˜์ง€ ์•Š์•„ Synthetic DID๊ฐ€ ๋ฐ˜๋“œ์‹œ ํ•„์š”ํ–ˆ๋Š”์ง€๋Š” ์˜๋ฌธ์ด ๋‚จ์Œ.

  • (๋น„๊ต๊ตฐ์˜ ์ด์งˆ์„ฑ) IPPS ๋ณ‘์›๊ณผ Maryland ๋ณ‘์›ยทCAHยทLTCH๋Š” ๋ณ‘์› ๊ทœ๋ชจ, ๊ต์œก๋ณ‘์› ์—ฌ๋ถ€, ์ง€์—ญ ๋“ฑ ๊ธฐ๋ณธ ํŠน์„ฑ์ด ์ƒ๋‹นํžˆ ๋‹ค๋ฆ„. Synthetic DID๋กœ ์‚ฌ์ „ ์ถ”์„ธ๋ฅผ ๋งž์ท„๋”๋ผ๋„ ์„œ๋กœ ๋‹ค๋ฅธ ์œ ํ˜•์˜ ๋ณ‘์›์ด ์ ์ ˆํ•œ counterfactual์ด ๋  ์ˆ˜ ์žˆ๋Š”์ง€๋Š” ๋ณ„๋„๋กœ ๊ณ ๋ คํ•  ํ•„์š”๊ฐ€ ์žˆ์Œ.


๐Ÿ“š์ด์ „์— ๋ฐœ์†ก๋˜์—ˆ๋˜ ์˜๋ฃŒ๊ฒฝ์˜ ๋‰ด์Šค๋ ˆํ„ฐ๋Š” ์•„์นด์ด๋ธŒ์—์„œ ๋ชจ์•„๋ณผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Follow us!
์—ฐ์„ธ๋Œ€ํ•™๊ต ์˜๋ฃŒ๊ฒฝ์˜์—ฐ๊ตฌ์‹ค
์ˆ˜์‹ ๊ฑฐ๋ถ€ Unsubscribe